相似文献
1
Immunotherapy of the Dunning leukaemia with thymic extracts.
Br J Cancer. 1973 Oct;28(4):288-92. doi: 10.1038/bjc.1973.150.
2
Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.
J Immunol. 1975 Jul;115(1):234-8.
3
Effect of tissue specific mitotic inhibitors on survival time of spontaneous and virus-induced murine leukaemia and influence on myocardial degeneration.
Scand J Haematol. 1978 Aug;21(2):131-8. doi: 10.1111/j.1600-0609.1978.tb02503.x.
4
Adoptive immunotherapy and combined chemo-immunotherapy in transplantable leukaemia of AKR mice (TAL); occurrence of natural killers.
Haematologia (Budap). 1981;14(2):137-46.
5
Immunopotentiation in mice bearing a spontaneous transplantable T-cell lymphoma: role of thymic extract.
Neoplasma. 2003;50(4):272-9.
6
A trial of immunologic stimulation with thymic extract (TFX) in untreated chronic lymphocytic leukemia.
Acta Med Pol. 1976;17(2):97-110.
7
Amplification of the proliferative response to alloantigen by a factor present in an extract of syngeneic thymic lymphoid cells.
Proc Natl Acad Sci U S A. 1978 Sep;75(9):4474-8. doi: 10.1073/pnas.75.9.4474.
8
Immune mechanisms in leukemia: protective capacity of the major lymphoid cell compartments.
J Immunol. 1976 Apr;116(4):976-81.
9
Effect of different components of the thymic stroma on the onset of AKR leukaemia.
Clin Exp Immunol. 1979 Sep;37(3):512-6.
10
Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.
Clin Exp Immunol. 1971 Jul;9(1):63-77.
引用本文的文献
1
Thymax, a gross thymic extract, exerts cell cycle arrest and apoptosis in Ehrlich ascites carcinoma in vivo.
Heliyon. 2022 Mar 5;8(3):e09047. doi: 10.1016/j.heliyon.2022.e09047. eCollection 2022 Mar.
2
Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications?
Vitam Horm. 2016;102:179-207. doi: 10.1016/bs.vh.2016.04.008. Epub 2016 May 27.
3
Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy.
Cancer Immunol Immunother. 2012 May;61(5):599-614. doi: 10.1007/s00262-012-1222-8. Epub 2012 Feb 26.
4
Modulation of terminal deoxynucleotidyl transferase activity by thymosin.
Mol Cell Biochem. 1981 Dec 4;41:49-58. doi: 10.1007/BF00225296.
5
Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations.
Proc Natl Acad Sci U S A. 1981 Feb;78(2):1162-6. doi: 10.1073/pnas.78.2.1162.
6
Immunotherapy of cancer with thymosin.
World J Surg. 1977 Sep;1(5):605-16. doi: 10.1007/BF01556187.
7
Effect of different components of the thymic stroma on the onset of AKR leukaemia.
Clin Exp Immunol. 1979 Sep;37(3):512-6.
8
Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.
Proc Natl Acad Sci U S A. 1977 Feb;74(2):725-9. doi: 10.1073/pnas.74.2.725.
本文引用的文献
1
A transplantable acute leukemia in an inbred line of rats.
J Natl Cancer Inst. 1957 Nov;19(5):845-53.
2
Influence of thymosin on immunological competence of lymphoid cells from thymectomized mice.
Nature. 1968 Sep 28;219(5161):1391-2. doi: 10.1038/2191391a0.
3
Impaired immunologic reactivity and recurrence following cancer surgery.
Cancer. 1970 Feb;25(2):362-7. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v.
4
Acceleration by thymosin of the development of resistance to murine sarcoma virus-induced tumor in mice.
Proc Natl Acad Sci U S A. 1970 Aug;66(4):1170-4. doi: 10.1073/pnas.66.4.1170.
5
Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin).
Proc Natl Acad Sci U S A. 1966 Sep;56(3):1010-7. doi: 10.1073/pnas.56.3.1010.
6
Essential relationship between the lymphoid system, immunity, and malignancy.
Natl Cancer Inst Monogr. 1969 Jul;31:41-58.
7
Effect of thymosin and an antithymosin serum on allograft survival in mice.
Proc Natl Acad Sci U S A. 1968 Nov;61(3):875-82. doi: 10.1073/pnas.61.3.875.
8
Biological effects of heterologous antilymphocyte serum.
Prog Allergy. 1970;14:208-58.
9
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone.
Proc Natl Acad Sci U S A. 1971 Nov;68(11):2734-8. doi: 10.1073/pnas.68.11.2734.
10
Reduction in the incidence of wasting disease in neonatally thymectomized CBA-W mice by the injection of thymosin.
Endocrinology. 1970 Mar;86(3):600-10. doi: 10.1210/endo-86-3-600.
Zotero 插件